Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α

in Journal of Endocrinology

Correspondence should be addressed to W Feng or J Wu or Y Bi: fengwh501@163.com or wuj@nju.edu.cn or biyan@nju.edu.cn

*(L Yu and H Wang contributed equally to this work)

Restricted access

Non-alcoholic fatty liver disease (NAFLD) is difficult to manage due to the lack of effective treatments. Increased oxygen consumption caused by overnutrition, along with reduced oxygen delivery to liver cells induces hepatic steatosis. Here, we investigated the efficacy of oxygen therapy (OT) to alleviate hepatic steatosis. The effect of OT on hepatic steatosis was evaluated in high-fat-diet (HFD)-fed mice and palmitic acid (PA)-treated primary hepatocytes. Liver biopsy tissue samples were used to determine the relationship between the expression of hypoxia-inducible factor-2α (HIF-2α) and the progression of NAFLD. The role of HIF-2α in the OT group was determined based on the overexpression of HIF-2α in vitro. OT safely alleviated hepatic hypoxia and improved hepatic steatosis by inhibiting hepatic de novo lipogenesis in HFD-fed mice and PA-treated primary hepatocytes, and this was accompanied by reduced expression of HIF-2α and hepatic de novo lipogenesis. The analysis of liver tissues from individuals with or without NAFLD revealed a positive correlation between hepatic HIF-2α expression and NAFLD progression. Overexpression of HIF-2α in vitro inhibited the beneficial effect of OT against hepatic lipogenesis and steatosis. OT might be a viable treatment option for NAFLD and functions by alleviating hypoxia and inhibiting the liver HIF-2α signaling pathway.

 

      Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 988 988 221
Full Text Views 52 52 10
PDF Downloads 23 23 4
  • AnaviSMadarZTiroshO 2017 Non-alcoholic fatty liver disease, to struggle with the strangle: oxygen availability in fatty livers. Redox Biology 13 386392. (https://doi.org/10.1016/j.redox.2017.06.008)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • BirchmeierW 2016 Orchestrating Wnt signalling for metabolic liver zonation. Nature Cell Biology 18 463465. (https://doi.org/10.1038/ncb3349)

  • ByrneCDTargherG 2015 NAFLD: a multisystem disease. Journal of Hepatology 62 (Supplement) S47S64. (https://doi.org/10.1016/j.jhep.2014.12.012)

  • CohenJCHortonJDHobbsHH 2011 Human fatty liver disease: old questions and new insights. Science 332 15191523. (https://doi.org/10.1126/science.1204265)

  • FebbraioMAReibeSShalapourSOoiGJWattMJKarinM 2019 Preclinical models for studying NASH-driven HCC: how useful are they? Cell Metabolism 29 1826. (https://doi.org/10.1016/j.cmet.2018.10.012)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • HannahWNJrHarrisonSA 2016 Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease. Digestive Diseases and Sciences 61 13651374. (https://doi.org/10.1007/s10620-016-4153-y)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • KietzmannT 2017 Metabolic zonation of the liver: the oxygen gradient revisited. Redox Biology 11 622630. (https://doi.org/10.1016/j.redox.2017.01.012)

  • KietzmannT 2019 Liver zonation in health and disease: hypoxia and hypoxia-inducible transcription factors as concert masters. International Journal of Molecular Sciences 20 2347. (https://doi.org/10.3390/ijms20092347)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • KohMYPowisG 2012 Passing the baton: the HIF switch. Trends in Biochemical Sciences 37 364372. (https://doi.org/10.1016/j.tibs.2012.06.004)

  • KoliakiCSzendroediJKaulKJelenikTNowotnyPJankowiakFHerderCCarstensenMKrauschMKnoefelWT 2015 Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metabolism 21 739746. (https://doi.org/10.1016/j.cmet.2015.04.004)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • KudchodkarBJPierceADoryL 2007 Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 193 2835. (https://doi.org/10.1016/j.atherosclerosis.2006.08.018)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • LiJGrigoryevDNYeSQThorneLSchwartzARSmithPLO’DonnellCPPolotskyVY 2005 Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. Journal of Applied Physiology 99 16431648. (https://doi.org/10.1152/japplphysiol.00522.2005)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • MantenaSKVaughnDPAndringaKKEcclestonHBKingALAbramsGADoellerJEKrausDWDarley-UsmarVMBaileySM 2009 High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochemical Journal 417 183193. (https://doi.org/10.1042/BJ20080868)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • MorelloESuttiSFogliaBNovoECannitoSBoccaCRajskyMBruzziSAbateMLRossoC 2018 Hypoxia-inducible factor 2alpha drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein. Hepatology 67 21962214. (https://doi.org/10.1002/hep.29754)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • PaisRBarrittASTCalmusYScattonORungeTLebrayPPoynardTRatziuVContiF 2016 NAFLD and liver transplantation: current burden and expected challenges. Journal of Hepatology 65 12451257. (https://doi.org/10.1016/j.jhep.2016.07.033)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • PiguetACStrokaDZimmermannADufourJF 2009 Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical Science 118 401410. (https://doi.org/10.1042/CS20090313)

    • Search Google Scholar
    • Export Citation
  • QuATaylorMXueXMatsubaraTMetzgerDChambonPGonzalezFJShahYM 2011 Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology 54 472483. (https://doi.org/10.1002/hep.24400)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • RamakrishnanSKShahYM 2017 A central role for hypoxia-inducible factor (HIF)-2alpha in hepatic glucose homeostasis. Nutrition and Healthy Aging 4 207216. (https://doi.org/10.3233/NHA-170022)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • RamakrishnanSKZhangHTakahashiSCentofantiBPeriyasamySWeiszKChenZUhlerMDRuiLGonzalezFJ 2016 HIF2alpha is an essential molecular brake for postprandial hepatic glucagon response independent of insulin signaling. Cell Metabolism 23 505516. (https://doi.org/10.1016/j.cmet.2016.01.004)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • Romero-GomezMZelber-SagiSTrenellM 2017 Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology 67 829846. (https://doi.org/10.1016/j.jhep.2017.05.016)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • RotmanYSanyalAJ 2017 Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut 66 180190. (https://doi.org/10.1136/gutjnl-2016-312431)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • SavranskyVBevansSNanayakkaraALiJSmithPLTorbensonMSPolotskyVY 2007 Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. American Journal of Physiology: Gastrointestinal and Liver Physiology 293 G871G877. (https://doi.org/10.1152/ajpgi.00145.2007)

    • Search Google Scholar
    • Export Citation
  • TsuneyamaKChenYCFujimotoMSasakiYSuzukiWShimadaTIizukaSNagataMAburadaMChenSY 2011 Advantages and disadvantages of hyperbaric oxygen treatment in mice with obesity hyperlipidemia and steatohepatitis. ScientificWorldJournal 11 21242135. (https://doi.org/10.1100/2011/380236)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • WeiKPiecewiczSMMcginnisLMTaniguchiCMWiegandSJAndersonKChanCWMulliganKXKuoDYuanJ 2013 A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by vegf inhibition. Nature Medicine 19 13311337. (https://doi.org/10.1038/nm.3295)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • XieCYagaiTLuoYLiangXChenTWangQSunDZhaoJRamakrishnanSKSunL 2017 Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis. Nature Medicine 23 12981308. (https://doi.org/10.1038/nm.4412)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation